Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Left-Right Design Evaluation of Pimecrolimus in Atopic Dermatitis
NCT02103725Phase 1Completed
- Sponsor
- LEO Pharma
- Start
- Apr 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Pimecrolimus vehicle + topical corticosteroid in atopic dermatitis (AD) (2 arms), sponsored by LEO Pharma. Primary endpoint: Total Sign Score on the treated area at 3 weeks. Started Apr 2014; status: completed.
02
Drugs
Pimecrolimus vehicle + topical corticosteroid
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02103725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02103725.